A simple score incorporating 6 clinical and angiographic characteristics can help predict the risk of clinically driven restenosis in patients receiving a drug-eluting stent (DES), according to a study based on a large, all-comers registry. The findings were published online July 6, 2010, ahead of print in Circulation: Cardiovascular Interventions.

To explore predictors of clinically driven TLR in the DES era, investigators led by David J. Cohen, MD, MSc, of St. Luke’s Mid America Heart Institute (Kansas City, MO), looked at 8,829 unselected patients who underwent DES implantation and were enrolled in the EVENT (Evaluation of Drug Eluting Stent and Ischemic Events) ....

You must be a member to access this content. To continue reading, please enter your username and password above.

If you have not yet registered, we would like to take this opportunity to welcome you to TCTMD - The Source for Interventional Cardiovascular News & Education.

If you are already a member, please re-enter your username and password above, and then click LOGIN.

For questions regarding the registration process, please refer to our FAQ documentation or contact customer service.